The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS

Fakultas Kedokteran Universitas Indonesia52 enrolled

Overview

This study aims to compare the effectiveness of Saccharomyces Boulardii vs Placebo in patient with Irritable Bowel Syndrome

This study aims to compare the effectiveness of Saccharomyces Boulardii vs Placebo in patient with Irritable Bowel Syndrome within timeframe of study 28 days and then will be examined the outcome as the improvement quality of life

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Irritable Bowel Syndrome

Interventions

Saccharomyces Boulardii 250 MGDRUG

Normagut capsule twice a day

PlaceboDRUG

Placebo capsule twice a day

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criterias: * 18 years or older * diagnosed with IBS based on ROME IV criteria * agree to be participant by signing inform consent Exclusion Criteria: * patient who does not want to sign the inform consent

Outcomes

Primary Outcomes

Clinical improvement quality of life within 29 days

Measuring quality of life using questionnaire IBS-QOL from 0-100, the higher the score, the better the outcome.

Time frame: 29 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.